CT/MSK: Anti-Inflammatory Drugs Flashcards

1
Q

Comment on the differences between ACUTE and CHRONIC inflammation in terms of:

histology (content of cellular infiltrate)
onset
vascular dilation permeability
drug treatments

A

Acute

  • Neutrophils
  • faster onset
  • more vascular dilation + permeability
  • Rx: NSAIDs, COX2, acetaminophen

Chronic

  • Mixed inflammatory cell infiltrate (macrophage, lymphocytes, plasma cells)
  • Slower onset and more protracted course
  • less vascular dilation + permeability
  • Rx: DMARDs, steroids, anti-biologics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the key step to initiating chronic inflammation?

A

leukotriene-mediated chemotaxis of cells to site of inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

T/F Acute inflammation always precedes chronic inflammation.

A

FALSE.

chronic inflammation CAN occur w/o acute inflammation (ie reactivation of dz, autoimmune disease)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Why wouldn’t use use NSAIDs to treat a chronic inflammation?

A

NSAIDs can provide some relief but will not resolve chronic inflammation (they block COX enzymes, but remember, the key step in initiation of chronic inflammation is leukotriene-mediated chemotaxis of cells to site of inflammation, which involves lipoxygenases)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Diagram the production of prostaglandins (generally) and indicate where these drugs will affect the pathway:

glucocorticoids
NSAIDs
COX2 inhibitors

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Rapid Associations:

Role of COX in GI protection

A

PGE2/PGI2 -> decrease proton pump activity & increase mucus secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Rapid Associations:

Role of COX in platelets

A

COX1 -> increase thromboxane A2 (TXA2) -> pro-thrombotic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Rapid Associations:

Role of COX in endothelial cells

A

COX2 –> increase prostacyclin -> anti-thrombosis + vasodilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Rapid Associations:

Role of COX in the kidney

A
  • COX1 functions in control of renal hemodynamics and GFR (produces prostglandins for vasodilation of afferent arteriole)
  • COX2 functions effect salt and water excretion (NSAID decreases PGI2 -> hyperkalemia and acute renal failure)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Rapid Associations:

Role of COX in the brain

A

COX3 -> does not actually exist!!! Ha..ha…ha

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the role of COX1? COX2?

A
  • *COX1** = homeostatic regulation: maintenance of normal renal function, gastric mucosal integrity, and hemostasis
  • expressed constitutively and synthesizes PGE2
  • *COX2** = induced in response to stress, infections, cytokines and inflammatory mediators (IL1, TNF, LPS, mitogens, ROS).
  • expression increases during inflammation/stress, and causes an increased PGE2; results in
  • vasodilation (redness, warmth, swelling)
  • pain transmission
  • fever (via signaling at the hypothalamus, which subsequently leads to the production of IL2, IL6, which drives fever and temperature)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are NSAIDs?

What organ systems do they affect and what is the mechanism by which it occurs? (4)

What are the toxicities? (6)

What are the contraindications? (2)

A
  • weak organic acids; **non-selective COX inhibitor **

**GI effects **- COX1 production of PGE2/PGI2 -> increased proton pump activity and decreased mucus production -> increased acid + decreased protective layer (managed with PPIs)

Platelet effects - COX1 inhibition - decreased thromboxane A2 -> limited thrombotic reaction

  • *Renal effects**
  • COX1 inhibition -> decreased PGE2 -> Na retention (low FENA due to afferent arteriole vasoconstriction), increased BP/weight (H2O retention) and CHF (rare)
  • COX2 inhibition -> decreased PGI2 -> hyperkalemia and acute renal failure
  • *Pathophysiology effects**
  • COX inhibition -> decreased inflammation, pain, fever)
  • *Toxicities**
  • GI Toxicity
  • Bleeding
  • CNS toxicity (at very high doses)
  • Salicylism (tinnitus, nausea, vomiting)
  • Anaphylactic shock
  • Fluid retention and renal distress/failure

Contraindications

  • 3rd trimester of pregnancy (PGE2 maintains patency of ductus arteriosus): NSAIDs can cause premature PDA closure in utero
  • children with viral fever: NSAIDs can cause Reyes Syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Do NSAIDs affect the leukotriene pathways?

A

most do not inhibit leukotriene synthesis, therefore if COX activity is inhibited, then there is an accumulation of arachadonic acid that can get shunted into the leukotriene pathways.

Reason why you can get NSAID-induced asthma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which one is reversible and which one is irreversible?

NSAIDs

Aspirin

A

NSAIDS - REVERSIBLE

Aspirin - IRREVERISBLE)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why are COX2 selective inhibitors taken off the market at one point?

A

Endothelial cells – COX2 inhibition - decreased prostacyclin production -> vasoconstricton + increased thrombotic event (since platelets are still capable of initiating thrombosis)

increased risk of cardiac events and stroke

(but do not cause bleeding problems, renal complications)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the mechanism by which Acetaminophen acts?

What is the main toxicity?

A

mechanism is unknown, but it is still widely prescribed.

hepatotoxicity/liver failure

17
Q

What are the 3 main DMARDs we should know?

A
  • Methotrexate
  • Leflunomide (Arava)
  • Sulfasalazine (combination of sulfapyridine + 5-aminosalicylic acid (mesalamine))
18
Q

How does Methotrexate work?

Onset of action?

Indications?

Contraindications?

ADR?

A

MoA Inhibit folate metabolism -> decreased DNA synthesis

Onset of action: 3-6 weeks

Indications: RA

ADR: alopecia, skin pigmentation, hepatotoxicity, pulmonary toxicity, myelosuppression nephrotoxicity, GI problems (nausa, loose stools), stomatitis, CNS effects (HA, impaired ability to concentrate), alopecia

Contraindications: pregnancy, lactation, alcoholism, blood disorders, immunodeficiency

19
Q

How does Leflunomide work?

Duraction of action?

Indications?

ADR?

A

MoA: pro-drug that inhibits pyrimidine biosynthesis -> decreased DNA synthesis, decreased histamine release + COX2 expression

Long half-life

Indications: RA

ADR: similar GI effects as MTX (nausa, loose stools), but slightly more hepatic side effects than MTX

20
Q

How does Sulfasalazine work?

How does it compare to MTX and leflunomide?

Indications?

Contraindications?

ADR?

A

Sulfasalazine (combination of sulfapyridine + 5-aminosalicylic acid (mesalamine))

  • Sulfapyridine – free radical scavenger in the joint
  • mesalamine – inhibit COX and lipoxygenase

more toxic than MTX and leflunomide

indications: ulcerative colitis, RA, Crohn’s, sometimes SLE patients

Contraindications: NSAIDs, patients with sulfa or salicylate allergies

ADR: rash, nausea, CNS effects (dizziness, HA), leukopenia

21
Q

How do anti-TNFa biologics work?

How are they proudced and why is this relevant?

What are the pros/cons of using this?

What are the 3 main types of anti-TNF biologics?

A

antibody directed aganist TNFa (central pro-inflammatory cytokine of chronic inflammation (involved in autoimmune d/o, IBD))

humanized forms prevent immune response from removing it (improved clinical tolerance)

Pros: greater stability of the antibody

Cons: $$$$$$

Infliximab (Remicade)
Adalimumab (Humira)
Etanercept (Enbrel)

22
Q

What is the difference between the structure of?

Infliximab (Remicade)
Adalimumab (Humira)
Etanercept (Enbrel)?

A

Infliximab - Humanized mouse monoclonal antibody directed against TNFa (Composed of human constant and murine variable regions)

Adalimumab - Recombinant human anti-TNFa (completely humanized, better tolerated)

Etanercept - Recombinant TNF receptor moieties linked to Fc heavy chain of human IgG (no light chains)

23
Q

Infliximab (Remicade)

structure?

administration
(how it’s given and precautions to consider)

indications

ADR/cons

Contraindications

A

Humanized mouse monoclonal antibody directed against TNFa (composed of human constant and murine variable regions)

Administration: IV,
Can be given with MTX
Caution for use in recently-vaccinated patients

Indication
*Ankylosing spondylitis
*RA, Juvenile RA
*Psoriasis
*Psoriatic arthritis
Crohns
Bechet’s Syndrome

(* indicates that it can also be treated with Adalimumab, Etanercept)

ADR: More likely to develop human-anti-chimeric antibodies, $$$

Contraindications: Patients with infections (active recurrent, chronic) because Infliximab affect host defenses against infections

24
Q

Adalimumab (Humira)

structure?

administration
(how it’s given and precautions to consider)

indications

ADR/cons

A

Recombinant human anti-TNFa (completely humanized, better tolerated)

Administration:IV
Can be given with MTX
Caution for use in recently-vaccinated patients

Indication
*Ankylosing spondylitis
*RA, Juvenile RA
*Psoriasis
*Psoriatic arthritis

(* indicates that it can also be treated with Infliximab, Etanercept)

ADRs: Less likely to develop human-anti-chimeric antibodies, $$$

25
Q

Etanercept (Enbrel)

structure?

administration
(how it’s given and precautions to consider)

indications

ADR/cons

Contraindications

A

Recombinant TNF receptor moieties linked to Fc heavy chain of human IgG (no light chains)

Administration:IV or sub-cu
Can be given with MTX
Caution for use in recently-vaccinated patients

Indications:
Chronic pain due to long-half-life
*Ankylosing spondylitis
*RA, Juvenile RA
*Psoriasis
*Psoriatic arthritis

(* indicates that it can also be treated with Infliximab, Adalimumab (Humira)

ADR: $$$

Contraindications: Use with other myelosuppressive anti-rheumatic agents due to increased risk of developing pancytopenia (aplastic anemia)

26
Q

What is the mechanism of action for corticosteroids?

(hydrocortisone (cortisol), prednisone and triamcinolone)

What are the effects mediated by?

What is the net effect of using it?

Indications for corticosteroid use?

Contraindications?

A

block the transition from acute inflammation -> immune response via:

  • decreased cytokines
  • decreased leukocyte number & activity
  • decreased humoral responses
  • decreased COX2 gene expression

anti-inflammatory actions of corticosteroids are thought to be mediated by lipocortins, which inhibit the release of arachidonic acid (thereby inhibiting the production of prostaglandins and leukotrienes)

net effects:

  • decreased edema or scar tissue
  • suppression in immune response

Indication:
- RA, autoimmune dysfunction

Contraindicated for patients with:

  • Peptic ulcer
  • Heart disease or hypertension with CHF
  • Infections (especially herpes simplex), diabetes, osteoporosis
  • Psychoses
  • Hepatic dysfunction
27
Q

What cell lineages does corticosteroids affect?

A

lymphotoxic properties

no apparent toxicity on myeloid or RBC lineages
(it suppresses myeloid line without killing it)

28
Q

What are some of the effects due to long-term use of glucocorticoid steroids?

A

Cushing-like syndrome

Telangeictasia

HPA suppression (via negative feedback to suppress ACTH production)

Mineralocorticoid effects (increase Na and H2O retention)

increased protein catabolism and diversion of a.a. to glucose metabolism - increased need for insulin - weight gain, visceral fat deposition, muscle wasting, and hyperglycemia

peptic ulcers

hypomania or acute psychosis, depression

29
Q

What is Behcet’s Syndrome?

What is a drug that can be used to treat it?

A

Behcet’s Syndrome: recurring crops of mouth ulcers (aphthous ulcers), genital ulcers, and inflammation of uvea (uveitis)

Trmt: Infliximab

(think - you would never want to inflict this kind of d/o on anyone else!)